Skip to main content
Top
Published in: Supportive Care in Cancer 6/2010

01-06-2010 | Special Article

Adolescent oncology: who cares?—the new KID on the block

Author: Vivek Subbiah

Published in: Supportive Care in Cancer | Issue 6/2010

Login to get access

Abstract

The paper reports a case of a 25-year-old male with a new diagnosis of acute lymphoblastic leukemia admitted in a predominantly older adult cancer ward. It explores the emerging area of adolescent oncology. Despite the advances of modern cancer medicine in both survival and outcomes, these adolescent and young adult cancer patients are an underserved group. Their medical, physical, psychological, and emotional needs are different and ought to be managed differently, just like pediatric or geriatric subpopulations. Cancer adds an enormous burden to the already turbulent period of adolescence. Cancer incidence in the 15–29-year age group is at least three times than that of those younger than 15 years of age, and it kills more young adults than any disease except depression-induced suicide. The need for optimizing and personalizing care in this age group is highlighted.
Literature
2.
go back to reference Bleyer WA, O'Leary M, Barr R, Ries LAG (eds) (2006) Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975–2000. National Cancer Institute, Bethesda (NIH Pub. No. 06-5767) Bleyer WA, O'Leary M, Barr R, Ries LAG (eds) (2006) Cancer epidemiology in older adolescents and young adults 15 to 29 years of age, including SEER incidence and survival: 1975–2000. National Cancer Institute, Bethesda (NIH Pub. No. 06-5767)
3.
go back to reference Ferrari A, Montello M, Budd T, Bleyer A (2008) The challenges of clinical trials for adolescents and young adults with cancer. Pediatr Blood Cancer 50:1101–1104CrossRefPubMed Ferrari A, Montello M, Budd T, Bleyer A (2008) The challenges of clinical trials for adolescents and young adults with cancer. Pediatr Blood Cancer 50:1101–1104CrossRefPubMed
4.
go back to reference Bleyer A, Barr R, Hayes-Lattin B, Thomas D, Ellis C, Anderson B (2008) The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer 8:288–298CrossRefPubMed Bleyer A, Barr R, Hayes-Lattin B, Thomas D, Ellis C, Anderson B (2008) The distinctive biology of cancer in adolescents and young adults. Nat Rev Cancer 8:288–298CrossRefPubMed
5.
go back to reference Albritton KH, Wiggins CH, Nelson HE, Weeks JC (2007) Site of oncologic specialty care for older adolescents in Utah. J Clin Oncol 25:4616–4621CrossRefPubMed Albritton KH, Wiggins CH, Nelson HE, Weeks JC (2007) Site of oncologic specialty care for older adolescents in Utah. J Clin Oncol 25:4616–4621CrossRefPubMed
6.
go back to reference Bleyer A (2007) Adolescent and young adult (AYA) oncology: the first A. Pediatr Hematol Oncol 24:325–336CrossRefPubMed Bleyer A (2007) Adolescent and young adult (AYA) oncology: the first A. Pediatr Hematol Oncol 24:325–336CrossRefPubMed
7.
go back to reference Bleyer A (2005) The adolescent and young adult gap in cancer care and outcome. Curr Probl Pediatr Adolesc Health Care 35:182–217CrossRefPubMed Bleyer A (2005) The adolescent and young adult gap in cancer care and outcome. Curr Probl Pediatr Adolesc Health Care 35:182–217CrossRefPubMed
8.
go back to reference Bleyer A (2010) The Quid Pro Quo of pediatric versus adult services for older adolescent cancer patients. Pediatr Blood Cancer 54:238–241PubMed Bleyer A (2010) The Quid Pro Quo of pediatric versus adult services for older adolescent cancer patients. Pediatr Blood Cancer 54:238–241PubMed
Metadata
Title
Adolescent oncology: who cares?—the new KID on the block
Author
Vivek Subbiah
Publication date
01-06-2010
Publisher
Springer-Verlag
Published in
Supportive Care in Cancer / Issue 6/2010
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-010-0861-6

Other articles of this Issue 6/2010

Supportive Care in Cancer 6/2010 Go to the issue

Letter to the Editor

Letter to the editor

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine